Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763
Article CAS PubMed Google Scholar
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing 39(4):412–423
Article PubMed PubMed Central Google Scholar
Tournadre A, Vial G, Capel F, Soubrier M, Boirie Y (2019) Sarcopenia. Joint Bone Spine 86(3):309–314
An HJ, Tizaoui K, Terrazzino S, Cargnin S, Lee KH, Nam SW et al (2020) Sarcopenia in autoimmune and rheumatic diseases: a comprehensive review. Int J Mol Sci 21(16):5678
Article CAS PubMed PubMed Central Google Scholar
Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA et al (2020) Sarcopenia definition: the position statements of the Sarcopenia definition and outcomes consortium. J Am Geriatr Soc 68(7):1410–1418
Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr 29(2):154–159
Article CAS PubMed Google Scholar
Cao L, Morley JE (2016) Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) code. J Am Med Dir Assoc 17(8):675–677
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31
Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E et al (2005) Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 64(10):1431–1435
Article CAS PubMed PubMed Central Google Scholar
Valido A, Crespo CL, Pimentel-Santos FM (2019) Muscle evaluation in axial spondyloarthritis-the evidence for Sarcopenia. Front Med (Lausanne) 6:219
Aguiar R, Sequeira J, Meirinhos T, Ambrosio C, Barcelos A (2014) SARCOSPA - Sarcopenia in spondyloarthritis patients. Acta Reumatol Port 39(4):322–326
El Maghraoui A, Ebo’o FB, Sadni S, Majjad A, Hamza T, Mounach A (2016) Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis? BMC Musculoskelet Disord 17:268
Article PubMed PubMed Central Google Scholar
Barone M, Viggiani MT, Anelli MG, Fanizzi R, Lorusso O, Lopalco G et al (2018) Sarcopenia in patients with rheumatic diseases: prevalence and associated risk factors. J Clin Med. 7(12):504
Article PubMed PubMed Central Google Scholar
Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A, Placek W (2017) Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis. Reumatologia 55(5):215–221
Article PubMed PubMed Central Google Scholar
Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD (2007) Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res 22(3):425–433
Nagy H, Sornay-Rendu E, Boutroy S, Vilayphiou N, Szulc P, Chapurlat R (2013) Impaired trabecular and cortical microarchitecture in daughters of women with osteoporotic fracture: the MODAM study. Osteoporos Int 24(6):1881–1889
Article CAS PubMed Google Scholar
Chaitou A, Boutroy S, Vilayphiou N, Munoz F, Delmas PD, Chapurlat R et al (2010) Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study. J Bone Miner Res 25(11):2313–2323
Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 40(4):423–429
Neumann S, Kwisda S, Krettek C, Gaulke R (2017) Comparison of the grip strength using the martin-vigorimeter and the JAMAR-dynamometer: establishment of normal values. In Vivo 31(5):917–924
PubMed PubMed Central Google Scholar
Andreoli A, Scalzo G, Masala S, Tarantino U, Guglielmi G (2009) Body composition assessment by dual-energy X-ray absorptiometry (DXA). Radiol Med 114(2):286–300
Article CAS PubMed Google Scholar
Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I et al (2015) Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 44(6):960–966
Article PubMed PubMed Central Google Scholar
Marcora S, Casanova F, Williams E, Jones J, Elamanchi R, Lemmey A (2006) Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis. Rheumatology (Oxford) 45(11):1385–1388
Article CAS PubMed Google Scholar
Beenakker KG, Ling CH, Meskers CG, de Craen AJ, Stijnen T, Westendorp RG et al (2010) Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 9(4):431–436
Article PubMed PubMed Central Google Scholar
Kim SC, Lee YG, Park SB, Kim TH, Lee KH (2017) Muscle mass, strength, mobility, quality of life, and disease severity in ankylosing spondylitis patients: a preliminary study. Ann Rehabil Med 41(6):990–997
Article PubMed PubMed Central Google Scholar
Dos Santos FP, Constantin A, Laroche M, Destombes F, Bernard J, Mazieres B et al (2001) Whole body and regional bone mineral density in ankylosing spondylitis. J Rheumatol 28(3):547–549
Toussirot E, Michel F, Wendling D (2001) Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 40(8):882–888
Article CAS PubMed Google Scholar
Ben Tekaya A, Mehmli T, Ben Sassi M, Teyeb Z, Bouden S, Rouached L et al (2022) Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. https://doi.org/10.1007/s10067-022-06454-y
Reiss J, Iglseder B, Alzner R, Mayr-Pirker B, Pirich C, Kassmann H et al (2019) Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age Ageing 48(5):719–724
Article CAS PubMed Google Scholar
Locquet M, Beaudart C, Petermans J, Reginster JY, Bruyere O (2019) EWGSOP2 versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc 20(3):384–385
Yang L, Yao X, Shen J, Sun G, Sun Q, Tian X et al (2020) Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents. Exp Gerontol 130:110798
Article CAS PubMed Google Scholar
Warzecha M, Amarowicz J, Berwecka M, Czerwinski E, Kumorek A (2020) Relation between risk of falls, sarcopenia and parameters assessing quality of skeletal muscles in a group of postmenopausal women. Menopause Rev 19(3):123–129
Wallengren O, Bosaeus I, Frandin K, Lissner L, Falk Erhag H, Wetterberg H et al (2021) Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults. BMC Geriatr 21(1):600
Article PubMed PubMed Central Google Scholar
Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE (2018) Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep 20(6):35
Article CAS PubMed PubMed Central Google Scholar
Maas F, Arends S, van der Veer E, Wink F, Efde M, Bootsma H et al (2016) Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome. J Rheumatol 43(2):383–387
Article CAS PubMed Google Scholar
Ibanez Vodnizza S, Visman IM, van Denderen C, Lems WF, Jaime F, Nurmohamed MT et al (2017) Muscle wasting in male TNF-alpha blocker naive ankylosing spondylitis patients: a comparison of gender differences in body composition. Rheumatology (Oxford) 56(9):1566–1572
Rusman T, van Bentum RE, van der Horst-Bruinsma IE (2020) Sex and gender differences in axial spondyloarthritis: myths and truths. Rheumatology (Oxford) 59(Supplement_4):38–46
Toussirot E (2020) The interrelations between biological and targeted synthetic agents used in inflammatory joint diseases, and obesity or body composition. Metabolites 10(3):107
留言 (0)